Silent Crisis: India’s Stem Cell Donor Shortage Leaves Thousands of Blood Cancer Patients Without Hope

Published: May 29, 2026 | New Delhi, India

Thousands of blood cancer patients across India are facing a critical life-or-death bottleneck due to a severe shortage of registered blood stem cell donors. Despite boasting a population of 1.4 billion people, India has registered a mere 0.09% of its eligible population as potential blood stem cell donors.

Hematologists and transplant specialists warn that this figure is catastrophically low for a nation where over 100,000 individuals are diagnosed with blood cancers annually. For the vast majority of these patients, finding a matching, unrelated donor within India’s genetically diverse population is akin to finding a needle in a haystack—frequently with fatal consequences.

The Scope of the Crisis

Every five minutes, someone in India is diagnosed with blood cancer or a severe blood disorder, according to data from the DKMS Foundation India, a non-profit organization dedicated to connecting patients with matching donors. The annual toll of this public health crisis is staggering: more than 100,000 new blood cancer cases are diagnosed each year, resulting in over 70,000 annual deaths.

For patients battling aggressive malignancies like leukemia, lymphoma, and multiple myeloma, as well as severe non-malignant conditions like aplastic anemia, a blood stem cell transplant often represents the only definitive cure. However, approximately 70% of patients who require a transplant do not have a matching sibling within their family. They must rely entirely on unrelated anonymous donors. Because of India’s unique and complex genetic architecture, the probability of finding a matching unrelated donor ranges from 1 in 10,000 to less than 1 in a million.

Why Stem Cell Transplants Are Critical

Blood stem cell transplantation, historically referred to as bone marrow transplantation, replaces a patient’s diseased or treatment-damaged stem cells with healthy, blood-forming cells. This intervention is crucial for patients with aggressive hematological diseases that fail to achieve long-term remission through conventional chemotherapy alone.

Clinical data from the National Institutes of Health (NIH) demonstrate that timely stem cell transplantation significantly improves long-term survival and disease-free remission rates. However, the therapeutic window for a successful transplant is notoriously narrow.

Dr. Esha Kaul, Director of Haemato-Oncology and Bone Marrow Transplant at Medanta Super Speciality Hospital in Noida, emphasizes the critical temporal element:

“Blood cancers can progress very rapidly, and for many patients, a stem cell transplant offers the best chance of survival. However, one of the biggest challenges we continue to face in India is the delay in finding a suitable matching donor in time. In aggressive blood cancers, delays of even a few months while searching for a donor can significantly impact treatment outcomes and survival chances.”

The Genetics of Matching: Why Ethnicity Matters

The primary barrier to successful transplantation is Human Leukocyte Antigen (HLA) compatibility. HLAs are specialized proteins found on the surface of most cells in the body, acting as genetic markers that the immune system uses to recognize self from non-self. Because HLA types are deeply tied to ancestral lineages and inherited genetically, a patient’s best chance of finding a match lies within their own ethnic community.

“A person of Indian origin is far more likely to find a matching donor from another Indian than from someone of another ethnic background,” notes the DATRI Blood Stem Cell Donors Registry, India’s largest unrelated donor registry.

India’s highly heterogeneous population—shaped by centuries of endogamous marriage practices across diverse subgroups—creates an extraordinarily complex HLA landscape. This makes a massive, localized registry absolutely vital. Currently, while India constitutes over 20% of the global population, its registered donors account for less than 1% of the global stem cell database.

Registry Size Compared Globally

The stark disparity between India’s donor pool and those of other developed nations highlights the scale of under-registration:

Patrick Paul, Executive Chairman of DKMS Foundation India, points out that the registry’s current geographic concentration further complicates recruitment. While metropolitan hubs like Delhi, Mumbai, Bengaluru, Hyderabad, Chennai, and Pune show higher registration rates due to corporate CSR campaigns and localized healthcare access, participation from Tier-2, Tier-3, and rural sectors remains critically low.

“Participation from young individuals, educational institutions, corporates, and communities is critical to help strengthen the donor registry and give more patients a second chance at life,” Paul emphasizes.

Delayed Diagnosis Compounds the Problem

The donor shortage is compounded by systemic delays in early medical intervention. Many patients lose valuable time navigating a fragmented primary care system before receiving an accurate diagnosis.

Dr. Aruna Rajendran, Assistant Professor in the Department of Hematology at the Institute of Child Health and Hospital for Children in Chennai, notes:

“Many patients spend weeks or even months visiting general physicians for symptoms they assume are viral infections, simple anemia, or fatigue before a specialist is consulted.”

Common red flags for blood cancer include:

• Persistent, unexplained fatigue and weakness

• Recurrent infections or slow-healing illnesses

• Unexplained, low-grade fevers and night sweats

• Easy bruising or unusual bleeding (such as bleeding gums)

• Swollen lymph nodes in the neck, armpits, or groin

• Persistent bone and joint pain

• Sudden, unexplained weight loss

Clinical outcomes degrade significantly when aggressive blood cancers are allowed to progress to advanced stages prior to a hematological referral.

Dismantling the Myths: The Reality of Donation

Widespread misconceptions about the donation process remain a primary deterrent to registration. “Many people still believe the process is painful or highly invasive, whereas in most cases, donation is similar to blood donation and recovery is usually quick,” explains Dr. Nitin Agarwal, Head of Donor Request Management at DKMS Foundation India.

Medical advancements have largely replaced surgical bone marrow harvesting with non-invasive techniques:

• Peripheral Blood Stem Cell (PBSC) Donation: Approximately 90% of all stem cell donations are now performed via PBSC apheresis. This is a non-surgical, outpatient procedure identical to blood platelet donation.

• Minimal Disruption: The apheresis process takes roughly 4 to 8 hours in a single session. Donors routinely return to work and regular daily activities within 1 to 7 days.

• Natural Regeneration: The donor’s body naturally replenishes the donated blood stem cells within a few weeks.

• High Safety Profile: Long-term data from the National Marrow Donor Program (NMDP) show that fewer than 1% of donors experience any serious side effects.

Who Can Register?

Any healthy adult between the ages of 18 and 50 can join the registry via a non-invasive cheek swab that collects DNA for HLA typing. Registries place a premium on younger donors (aged 18 to 35), as clinical studies consistently link younger donor stem cells with superior engraftment success and improved post-transplant survival rates.

Real-World Limitations and Challenges Ahead

Expanding the pool is not a simple matter of increasing registry sign-ups. Registry coordinators face a severe secondary hurdle: donor attrition.

According to data from DKMS Foundation India, approximately 60% of registered Indian donors decline to proceed when they are identified as a match for a patient and asked to donate. This high withdrawal rate is typically driven by familial pressure, deeply rooted cultural anxieties, or lingering fears about medical safety.

Furthermore, data published in The Lancet Haematology indicates that the baseline match probability for South Asian patients remains severely compromised by genetic diversity. Without a massive influx of committed, diverse registrants, the matching success rate will remain highly volatile.

A Direct Imperative for the Public

The structural deficit in India’s stem cell registry turns an otherwise treatable medical condition into a fatal diagnosis for thousands. For health-conscious citizens, addressing this crisis involves tangible steps:

1. Registering as a Donor: If you are between 18 and 50 and in good health, a simple cheek swab can place you on the national registry.

2. Sustaining Commitment: Registration is a commitment to donate if called upon. Educating oneself and one’s family prevents withdrawal at critical moments.

3. Symptom Awareness: Do not ignore prolonged fatigue, recurrent fevers, or unexplained bruising. Early consultation with a hematologist saves lives.

As healthcare communities observe World Blood Cancer Day, the directive from public health officials is clear. Resolving India’s stem cell deficit requires shifting public perception from fear to civic responsibility. With 70,000 lives lost annually, expanding the national registry is an urgent public health imperative.

Medical Disclaimer

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.

References

• https://www.ndtv.com/health/india-faces-severe-stem-cell-donor-crisis-for-blood-cancer-patients-say-experts-11555178